Former Executive Vice President, Chief Financial Officer · BIOMARIN PHARMACEUTICAL INC (BMRN)

Daniel Spiegelman

A named executive officer of BIOMARIN PHARMACEUTICAL in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,309,976

Salary $449,519Stock awards $0

FY2019: $5,239,902

7th of 7 named executive officers at Biomarin Pharmaceutical by FY2020 total.

7 named officers on file for BIOMARIN PHARMACEUTICAL, FY2020

Daniel Spiegelman’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • BMRN’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIOMARIN PHARMACEUTICAL’s whole pay program stands against its peers

  • BIOMARIN PHARMACEUTICAL’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BMRN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 13, 2021 (DEF 14A).

Free

Get Daniel Spiegelman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Daniel Spiegelman compensation by year

BIOMARIN PHARMACEUTICAL Summary Compensation Table · all 5 fiscal years held
In US dollars, as BIOMARIN PHARMACEUTICAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$530,192$559,231$593,269$620,192$449,519
Bonus$0$0$0$0$0
Stock awards$2,380,258$2,133,048$2,085,908$3,120,022$0
Option awards$1,584,825$1,439,891$1,335,054$867,181$0
Non-equity incentive$382,793$481,380$482,400$600,000$0
Pension and deferred compensation$0$0$0$0$0
All other$21,135$28,325$25,072$32,507$1,860,457
Total$4,899,203$4,641,875$4,521,703$5,239,902$2,309,976

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOMARIN PHARMACEUTICAL INC DEF 14A filed April 13, 2021, accession 0001206774-21-001100, and prior-year filings.

How this page was built: the BIOMARIN PHARMACEUTICAL INC filed document, accession 0001206774-21-001100. Every figure is read from that document and cited to the page and table it appears in. Filed April 13, 2021.

$4.9M
$4.6M
$4.5M
$5.2M
$2.3M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

BIOMARIN PHARMACEUTICAL’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jean-Jacques BienaiméChief Executive Officer$18,119,133
Henry FuchsPresident, Worldwide R&D$7,456,575
C. Greg GuyerChief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations$6,343,499
Brian MuellerExecutive Vice President, Chief Financial Officer$5,840,531
Robert BaffiFormer President of Global Manufacturing and Technical Operations$4,688,701
Jeff AjerExecutive Vice President, Chief Commercial Officer$4,536,436
Daniel Spiegelman · this pageFormer Executive Vice President, Chief Financial Officer$2,309,976

The full BIOMARIN PHARMACEUTICAL compensation record

free company brief

This page is one person within BIOMARIN PHARMACEUTICAL's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOMARIN PHARMACEUTICAL proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOMARIN PHARMACEUTICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Daniel Spiegelman's compensation dossier · One-time report. No refunds.